Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
China Everbright Bank Company Limited (601818.SS)
Beijing, CN
China Everbright Bank Company Limited delivers a wide spectrum of financial solutions and services to a diverse clientele, encompassing corporate enterprises, government bodies, and individual retail customers. Its operations span multiple international locations, including Mainland China, Hong Kong, Luxembourg, Seoul, and Sydney. The institution is structured into several key segments: Corporate Banking, Retail Banking, Financial Market Business, and other ancillary activities. The bank's offerings include various deposit options such as demand, term, collateralized, and notice accounts, alongside specialized RMB general and agreement deposits, structured deposit products, and certificates of deposit. Its lending portfolio features working capital loans, fixed asset financing, project funding, syndicated loans, entrusted loans, auto loans, personal advances, and overdraft facilities. Customers also have access to credit and debit cards. Beyond core banking, the company provides an extensive array of specialized financial services. These comprise bills acceptance, investment banking, trade finance, agency services, cash management, financial consulting and advisory, remittance and settlement, guarantees, wealth management, and securities brokerage. It also engages in inter-bank money market transactions, investment activities, repurchase agreements, equity investments, leasing, capital market operations, asset management, treasury functions, and custodial services. Digital platforms further enhance its service delivery with online, mobile, and private banking options. Furthermore, China Everbright Bank is an active participant in trading debt instruments, derivatives, and foreign exchange. As of December 31, 2021, the bank boasted a significant domestic footprint, operating 1,304 branches and outlets across 150 major economic centers throughout China. Founded in 1992, its corporate headquarters are situated in Beijing, China.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.63% | +0.64% | -1.88% | -5.15% | -10.57% | -10.32% | -19.74% | -6.01% | -18.70% | -11.83% | -14.48% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 1 | 0 |
| Buy | 7 | 0 |
| Hold | 3 | 0 |
| Sell | 6 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth-10.0% Q1'26: -9.1% (vs Q1'25)
-
EPS growth-6.5% Q1'26: -8.3% (vs Q1'25)
-
FCF margin— Q1'26: +45.0% (vs Q1'25)
-
EBIT margin— Q1'26: +24.7% (vs Q1'25)
-
ROIC— Q1'26: +1.8% (vs Q1'25)
-
Share dilution-0.5% Q1'26: -9.9% (vs Q1'25)
-
Debt / EBITDA— Q1'26: 40.60× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2015 actual |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 3 Rev. Ana. 2 EPS Ana. |
Dec 2027 4 Rev. Ana. 6 EPS Ana. |
Dec 2028 4 Rev. Ana. 3 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
168.61B
est: 93.19B (+80.9%)
|
172.20B
est: 93.62B (+83.9%)
|
191.24B
est: 92.59B (+106.5%)
|
217.77B
est: 106.57B (+104.3%)
|
240.94B
est: 134.03B (+79.8%)
|
253.36B
est: 142.52B (+77.8%)
|
270.02B
est: 154.43B (+74.8%)
|
279.35B
est: 156.26B (+78.8%)
|
288.98B
est: 93.11B (+210.4%)
|
272.74B
est: 138.09B (+97.5%)
|
245.37B
est: 127.84B (+91.9%)
|
128.23B
126.64B – 129.37B
+0.3% YoY
|
132.53B
129.31B – 134.85B
+3.4% YoY
|
135.54B
135.39B – 135.68B
+2.3% YoY
|
| EBITDA |
41.46B
est: 19.45B (+113.2%)
|
42.36B
est: 19.54B (+116.8%)
|
42.78B
est: 19.33B (+121.4%)
|
43.02B
est: 22.24B (+93.4%)
|
49.63B
est: 27.97B (+77.4%)
|
50.48B
est: 29.75B (+69.7%)
|
58.39B
est: 32.23B (+81.1%)
|
61.93B
est: 32.61B (+89.9%)
|
56.07B
est: 19.98B (+180.6%)
|
57.93B
est: 29.63B (+95.5%)
|
56.08B
est: 27.43B (+104.4%)
|
27.52B
27.18B – 27.76B
+0.3% YoY
|
28.44B
27.75B – 28.94B
+3.4% YoY
|
29.08B
29.05B – 29.12B
+2.3% YoY
|
| EBIT |
39.36B
est: 17.46B (+125.4%)
|
40.18B
est: 17.54B (+129.0%)
|
40.65B
est: 17.35B (+134.2%)
|
40.85B
est: 19.97B (+104.5%)
|
45.16B
est: 25.12B (+79.8%)
|
45.53B
est: 26.71B (+70.5%)
|
52.94B
est: 28.94B (+82.9%)
|
55.97B
est: 29.28B (+91.1%)
|
49.76B
est: 17.87B (+178.4%)
|
51.47B
est: 26.51B (+94.2%)
|
49.69B
est: 24.54B (+102.5%)
|
24.62B
24.31B – 24.83B
+0.3% YoY
|
25.44B
24.82B – 25.89B
+3.4% YoY
|
26.02B
25.99B – 26.05B
+2.3% YoY
|
| Net Income |
29.53B
est: 42.69B (-30.8%)
|
30.33B
est: 42.74B (-29.0%)
|
31.55B
est: 42.15B (-25.2%)
|
33.66B
est: 41.77B (-19.4%)
|
37.35B
est: 47.59B (-21.5%)
|
37.84B
est: 45.29B (-16.5%)
|
43.41B
est: 51.22B (-15.2%)
|
44.81B
est: 52.56B (-14.7%)
|
40.79B
est: 41.59B (-1.9%)
|
41.70B
est: 42.41B (-1.7%)
|
38.83B
est: 42.95B (-9.6%)
|
41.10B
40.81B – 41.39B
-4.3% YoY
|
41.32B
37.67B – 44.97B
+0.5% YoY
|
42.24B
39.71B – 44.77B
+2.2% YoY
|
| SGA |
9.45B
est: 11.27B (-16.1%)
|
11.13B
est: 11.32B (-1.6%)
|
13.08B
est: 11.19B (+16.8%)
|
14.50B
est: 12.88B (+12.5%)
|
36.11B
est: 16.20B (+122.9%)
|
18.35B
est: 17.23B (+6.5%)
|
36.31B
est: 18.67B (+94.5%)
|
37.17B
est: 18.89B (+96.8%)
|
34.53B
est: 10.63B (+224.9%)
|
39.54B
est: 15.76B (+150.8%)
|
9.52B
est: 14.59B (-34.8%)
|
14.64B
14.46B – 14.77B
+0.3% YoY
|
15.13B
14.76B – 15.39B
+3.4% YoY
|
15.47B
15.46B – 15.49B
+2.3% YoY
|
| EPS |
0.63
est: 0.63 (-0.7%)
|
0.63
est: 0.64 (-0.9%)
|
0.64
est: 0.63 (+2.1%)
|
0.58
est: 0.62 (-6.6%)
|
0.68
est: 0.71 (-3.3%)
|
0.66
est: 0.67 (-2.0%)
|
0.71
est: 0.76 (-6.8%)
|
0.74
est: 0.78 (-5.3%)
|
0.62
est: 0.62 (-0.4%)
|
0.62
est: 0.63 (-2.4%)
|
0.58
est: 0.64 (-9.8%)
|
0.61
0.61 – 0.62
-4.5% YoY
|
0.63
0.56 – 0.67
+2.4% YoY
|
0.64
0.59 – 0.67
+1.8% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-11 | B+ | 3/5 | 5/5 | 2/5 | 3/5 | 1/5 | 4/5 | 4/5 |
| 2026-05-08 | B+ | 3/5 | 5/5 | 2/5 | 3/5 | 1/5 | 4/5 | 4/5 |
| 2026-05-07 | B+ | 3/5 | 5/5 | 2/5 | 3/5 | 1/5 | 4/5 | 4/5 |
| 2026-05-06 | B+ | 3/5 | 5/5 | 2/5 | 3/5 | 1/5 | 4/5 | 4/5 |
| 2026-04-30 | B+ | 3/5 | 5/5 | 2/5 | 3/5 | 1/5 | 4/5 | 4/5 |
| 2026-04-29 | A- | 4/5 | 5/5 | 3/5 | 3/5 | 1/5 | 4/5 | 4/5 |
| 2026-04-28 | A- | 4/5 | 5/5 | 3/5 | 3/5 | 1/5 | 4/5 | 4/5 |
| 2026-04-27 | A- | 4/5 | 5/5 | 3/5 | 3/5 | 1/5 | 4/5 | 4/5 |
| 2026-04-24 | A- | 4/5 | 5/5 | 3/5 | 3/5 | 1/5 | 4/5 | 4/5 |
| 2026-04-23 | A- | 4/5 | 5/5 | 3/5 | 4/5 | 1/5 | 4/5 | 4/5 |
| 2026-04-22 | A- | 4/5 | 5/5 | 3/5 | 4/5 | 1/5 | 4/5 | 4/5 |
| 2026-04-21 | A- | 4/5 | 5/5 | 3/5 | 4/5 | 1/5 | 4/5 | 4/5 |
| 2026-04-20 | A- | 4/5 | 5/5 | 3/5 | 4/5 | 1/5 | 4/5 | 4/5 |
| 2026-04-17 | A- | 4/5 | 5/5 | 3/5 | 4/5 | 1/5 | 4/5 | 4/5 |
| 2026-04-16 | A- | 4/5 | 5/5 | 3/5 | 4/5 | 1/5 | 4/5 | 4/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Kodex FTSE China A50 169950.KS | 0.76% | 116.9K | 0.12% |
| 2 | HSBC MSCI China A UCITS ETF HMCT.L | 0.48% | 648.0K | 0.30% |
| 3 | Desjardins RI Emerging Markets Multifactor - Net-Zero Emissions Pathway ETF DRFE.TO | 0.31% | 735.0K | 0.65% |
| 4 | Invesco FTSE Emerging Markets High Dividend Low Volatility UCITS ETF EMHD.L | 0.30% | 851.7K | 0.49% |
| 5 | Amundi MSCI China A UCITS ETF Acc CNAA.L | 0.29% | 401.3K | 0.35% |
| 6 | iShares MSCI China A ETF CNYA | 0.28% | 656.6K | 0.60% |
| 7 | iShares MSCI China A UCITS ETF CNYE.MI | 0.28% | 282.8K | 0.45% |
| 8 | iShares MSCI China A UCITS ETF CNYA.L | 0.28% | 8.57M | 0.40% |
| 9 | Xtrackers MSCI China A UCITS ETF 1C XX2D.L | 0.26% | 358.5K | 0.35% |
| 10 | Xtrackers Harvest CSI 300 China A-Shares ETF ASHR | 0.22% | 3.00M | 0.65% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Yongqi Wang | Executive Vice President | 2M | male |
| Bingbing Yang | Vice President & Executive Director | 2M | male |
| Ye Qi | Vice President & Executive Director | 2M | female |
| Cheng Hao | President & Executive Director | 790.0K | male |
| Song Bingfang | Secretary of Discipline Inspection | — | male |
| Tiefeng Dong | Deputy President | — | male |
| Siu Wai Yeung | Joint Company Secretary | — | female |
| Yan Li | Vice President & Chief Financial Officer | — | female |
| Bo Ma | Chief Risk Officer | — | male |
| Xuyang Zhang | Chief Business Officer, Board Secretary & Joint Company Secretary | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 601818.SS
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
